Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rulan Griesel
Observed names:
Griesel, Rulan,
R. Griesel
Institution:
ViiV Healthcare (United Kingdom)
Observed institutions:
University of Cape Town,
Groote Schuur Hospital,
ViiV Healthcare (United Kingdom),
Wellcome Centre for Infectious Diseases Research in Africa,
Institute of Infectious Disease and Molecular Medicine
ORCID:
0000-0003-3633-2878
Observed ORCID:
0000-0003-3633-2878
OpenAlex ID:
A5065861652
CheXaid: deep learning assistance for physician diagnosis of tuberculosis using chest x-rays in patients with HIV
2020
·
Pranav Rajpurkar
, Chloe O’Connell
, et al.
·
npj Digital Medicine
·
175
PDF
CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz
2020
·
Rulan Griesel
, Gary Maartens
, et al.
·
Clinical Infectious Diseases
·
105
PDF
Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient data
2020
·
David A Barr
, Joseph M Lewis
, et al.
·
The Lancet Infectious Diseases
·
95
PDF
Burden of pneumocystis pneumonia in HIV-infected adults in sub-Saharan Africa: a systematic review and meta-analysis
2016
·
Sean Wasserman
, Mark E. Engel
, et al.
·
BMC Infectious Diseases
·
68
PDF
Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV-positive individuals
2019
·
Daniel J Van Hoving
, Rulan Griesel
, et al.
·
Cochrane Database of Systematic Reviews
·
61
Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen
2021
·
Claire M. Keene
, Rulan Griesel
, et al.
·
AIDS
·
59
Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled trial
2023
·
Rulan Griesel
, Ying Zhao
, et al.
·
The Lancet HIV
·
47
PDF
C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study
2018
·
Fiona Mendelson
, Rulan Griesel
, et al.
·
BMC Infectious Diseases
·
46
PDF
Etiology of Pulmonary Infections in Human Immunodeficiency Virus–infected Inpatients Using Sputum Multiplex Real-time Polymerase Chain Reaction
2019
·
Gary Maartens
, Rulan Griesel
, et al.
·
Clinical Infectious Diseases
·
35
Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV
2018
·
Tom H. Boyles
, Rulan Griesel
, et al.
·
International Journal of Infectious Diseases
·
35
PDF
Optimizing Tuberculosis Diagnosis in Human Immunodeficiency Virus–Infected Inpatients Meeting the Criteria of Seriously Ill in the World Health Organization Algorithm
2017
·
Rulan Griesel
, Annemie Stewart
, et al.
·
Clinical Infectious Diseases
·
33
Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV-positive adults
2017
·
Daniel J Van Hoving
, Graeme Meintjes
, et al.
·
Cochrane Database of Systematic Reviews
·
29
PDF
Concentration–response relationships of dolutegravir and efavirenz with weight change after starting antiretroviral therapy
2021
·
Rulan Griesel
, Aida N. Kawuma
, et al.
·
British Journal of Clinical Pharmacology
·
24
PDF
Abdominal Ultrasound for the Diagnosis of Tuberculosis Among Human Immunodeficiency Virus-Positive Inpatients With World Health Organization Danger Signs
2019
·
Rulan Griesel
, Karen Cohen
, et al.
·
Open Forum Infectious Diseases
·
19
PDF
Development of a clinical prediction rule to diagnose Pneumocystis jirovecii pneumonia in the World Health Organization’s algorithm for seriously ill HIV-infected patients
2018
·
Gary Maartens
, Annemie Stewart
, et al.
·
Southern African Journal of HIV Medicine
·
19
PDF
Prognostic indicators in the World Health Organization’s algorithm for seriously ill HIV-infected inpatients with suspected tuberculosis
2018
·
Rulan Griesel
, Annemie Stewart
, et al.
·
AIDS Research and Therapy
·
18
PDF
Standard versus double dose dolutegravir in patients with HIV-associated tuberculosis: a phase 2 non-comparative randomised controlled (RADIANT-TB) trial
2021
·
Rulan Griesel
, Andrew Hill
, et al.
·
Wellcome Open Research
·
17
PDF
Recycling Tenofovir in Second-line Antiretroviral Treatment With Dolutegravir: Outcomes and Viral Load Trajectories to 72 weeks
2023
·
Claire M. Keene
, Tali Cassidy
, et al.
·
JAIDS Journal of Acquired Immune Deficiency Syndromes
·
16
PDF
Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population
2022
·
Rulan Griesel
, Phumla Sinxadi
, et al.
·
Journal of Antimicrobial Chemotherapy
·
12
AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trial
2021
·
Ying Zhao
, Claire Keene
, et al.
·
Wellcome Open Research
·
8
PDF
Relationship Between Tenofovir Diphosphate Concentrations in Dried Blood Spots and Virological Outcomes After Initiating Tenofovir–Lamivudine–Dolutegravir as First-Line or Second-Line Antiretroviral Therapy
2024
·
Jennifer Kate van Heerden
, Graeme Meintjes
, et al.
·
JAIDS Journal of Acquired Immune Deficiency Syndromes
·
7
PDF
Burden of pneumocystis pneumonia in HIV-infected adults in sub-Saharan Africa: A systematic review and meta-analysis
2016
·
S.A. Wasserman
, M. Engel
, et al.
·
International Journal of Infectious Diseases
·
7
Initial Supplementary Dose of Dolutegravir in Second-Line Antiretroviral Therapy: A Noncomparative, Double-Blind, Randomized Placebo-Controlled Trial
2023
·
Ying Zhao
, Rulan Griesel
, et al.
·
Clinical Infectious Diseases
·
6
PDF
Clinical Pharmacokinetics and Safety of Orally Administered VH4011499, a New HIV-1 Capsid Inhibitor, in Adults Without HIV
2025
·
Nilay Thakkar
, Rulan Griesel
, et al.
·
Infectious Diseases and Therapy
·
5
PDF
VH3810109 Efficacy, Safety, Pharmacokinetics, and Incidence of Antidrug Antibodies in Adults With HIV-1 Naive to Antiretroviral Therapy: BANNER Study Results
2025
·
Peter A Leone
, Alejandro Ferro
, et al.
·
The Journal of Infectious Diseases
·
4
PDF
Show more works
View as search
Works count:
53
Citation count:
967
H-index:
17
I10-index:
19
Year
Topic
Type